WHYS.video

Is Victoza (Liraglutide) Considered a High Risk Medication?

Learn why Victoza (liraglutide) is classified as a high-risk medication and the importance of consulting your healthcare provider before use.

Published

Video transcript

Victoza (liraglutide) is classified as a high-risk medication due to its potential side effects, including pancreatitis and thyroid tumors. It's important for patients to discuss the risks and benefits with their healthcare provider before starting treatment, and to follow all prescribed guidelines to mitigate potential adverse effects.

Questions and answers

  1. What are the main side effects of Victoza?

    Victoza may cause side effects such as pancreatitis, thyroid tumors, nausea, and gastrointestinal discomfort. It's important to monitor symptoms and consult your healthcare provider regularly.

  2. Why is Victoza considered a high-risk medication?

    Victoza is classified as high risk due to potential serious side effects, including inflammation of the pancreas and an increased risk of thyroid tumors, requiring careful medical supervision.

  3. Who should avoid taking Victoza?

    Patients with a history of pancreatitis, medullary thyroid carcinoma, or multiple endocrine neoplasia syndrome type 2 should avoid Victoza and discuss alternative treatments with their healthcare provider.

Related questions

Continue exploring

For more information on diabetes medications and their safety profiles, explore our related videos on GLP-1 receptor agonists and patient management strategies to stay informed and make safe treatment choices.